<?xml version="1.0" encoding="UTF-8"?>
<p>On the other hand, combination of the nucleoside analogue fluorouracil or the multikinase inhibitor midostaurin with palbociclib showed more limited effects, i.e., palbociclib partially enhanced the antiviral potency of fluorouracil or midostaurin in the presence of SAMHD1 (
 <xref ref-type="app" rid="app1-cancers-12-00713">Figure S2</xref>). Combination index calculation indicated synergy at specific concentrations, although CI were 100-fold lower compared to palbociclib-pemetrexed drug interactions (
 <xref rid="cancers-12-00713-t002" ref-type="table">Table 2</xref>) and antagonic or additive effects were also seen.
</p>
